Akoya Biosciences, Inc. (NASDAQ:AKYA) Q4 2023 Earnings Call Transcript March 4, 2024 Akoya Biosciences, Inc. beats earnings expectations. Reported EPS is $-0.22, expectations were $-0.27. AKYA isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day and thank you for […]
Akoya (AKYA) delivered earnings and revenue surprises of 18.52% and 1.41%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Here is how Acumen Pharmaceuticals, Inc. (ABOS) and Akoya Biosciences (AKYA) have performed compared to their sector so far this year.